Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Abbott Laboratories (NYSE:ABT).
Industry description
The investment seeks long-term growth of capital.
Under normal circumstances, the fund will invest at least 80% of net assets, plus the amount of any borrowings for investment purposes, in equity securities of companies in the health care and wellness sectors. It invests primarily in securities of U.S. companies, but may invest in foreign companies as well. The fund may invest in companies of any size. While the fund invests mainly in common stocks, it may also invest up to 20% of total assets in U.S. Treasury and U.S. agency debt obligations.
Market Cap
The average market capitalization across the DWS Health and Wellness A MF is 319.84B. The market cap for tickers in the group ranges from 176.41B to 994.49B. LLY holds the highest valuation in this group at 994.49B. The lowest valued company is ABT at 176.41B.
Volume
The average weekly volume growth across all stocks in the DWS Health and Wellness A MF was 37%. For the same stocks of the MF, the average monthly volume growth was 12% and the average quarterly volume growth was 15%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 14
P/E Growth Rating: 45
Price Growth Rating: 42
SMR Rating: 46
Profit Risk Rating: 50
Seasonality Score: -12 (-100 ... +100)